Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by NuCana plc
NuCana Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update
March 19, 2026
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Appoints Theresa Bruce as Chief Operating Officer
January 06, 2026
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma
December 10, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
November 05, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
October 18, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy
October 14, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Compliant with All Nasdaq Continued Listing Criteria
September 05, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
September 03, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update
August 20, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces ADS Ratio Change
August 01, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
July 21, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces Plan to Implement ADS Ratio Change
July 11, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Reports First Quarter 2025 Financial Results and Provides Business Update
June 02, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Prices $7 Million Registered Direct Offering
May 06, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
March 20, 2025
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update
November 25, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
November 11, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
September 25, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
September 14, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
August 29, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
August 15, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana to Present at the Jefferies Global Healthcare Conference
May 30, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
May 21, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
May 16, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 01, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces Completion of ADS Ratio Change
April 16, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
April 09, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
NuCana Announces Plan to Implement ADS Ratio Change
March 27, 2024
From
NuCana plc
Via
GlobeNewswire
Tickers
NCNA
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
